Inventor · disambiguated record
Klaus Bosslet
Also filed as: BOSSLET KLAUS
44 granted patents·11 pending applications·2,417 citations·filing 1992–2022
98Inventor score
Files withBEHRINGWERKE AG15AVENTIS PHARMA GMBH6HOECHST AG5BEHRING DIAGNOSTICS GMBH3DADE BEHRING MARBURG GMBH3
Top patents by PatentIndex Score
55 records- 0199US5830880AGene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compoundHOECHST AG·Filed 1995·Granted Nov 3, 1998·351 cites·52 claims
- 0296US5591828ABispecific and oligospecific mono-and oligovalent receptors, the preparation and use thereofBEHRINGWERKE AG·Filed 1994·Granted Jan 7, 1997·622 cites·10 claims
- 0395US5959083ATetravalent bispecific receptors, the preparation and use thereofBEHRINGWERKE AKTIENGELLSCHAFT·Filed 1994·Granted Sep 28, 1999·419 cites·9 claims
- 0495US5621002AProdrugs for enzyme mediated activationBEHRINGWERKE AG·Filed 1994·Granted Apr 15, 1997·217 cites·9 claims
- 0593US7129254B2Effector conjugates, process for their production and their pharmaceutical useSCHERING AG·Filed 2003·Granted Oct 31, 2006·51 cites·15 claims
- 0690US5561119AGlycosylated prodrugs, their method of preparation and their usesHOECHST LAB·Filed 1992·Granted Oct 1, 1996·107 cites·36 claims
- 0788US5955100AProdrugs their preparation and use as pharmaceuticalsBEHRINGWERKE AG·Filed 1995·Granted Sep 21, 1999·75 cites·16 claims
- 0884US6602688B1Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion proteins in E. coliAVENTIS PHARMA GMBH·Filed 1999·Granted Aug 5, 2003·43 cites·3 claims
- 0983US7335775B2Effector conjugates, process for their production and their pharmaceutical useSCHERING AG·Filed 2006·Granted Feb 26, 2008·5 cites·7 claims
- 1083US6548067B1Antigenic constructs of major histocompatibility complex class I antigens with specific carrier molecules, the preparation and use thereofFiled 1995·Granted Apr 15, 2003·47 cites·10 claims
- 1182US6146658AProdrugs, their preparation and use as pharmaceuticalsHOECHST AG·Filed 1997·Granted Nov 14, 2000·48 cites·8 claims
- 1282US5710134ACombination of necrosis-inducing substances with substances which are activated by necroses for the selective therapy of tumors and inflammatory disordersBEHRINGWERKE AG·Filed 1995·Granted Jan 20, 1998·54 cites·14 claims
- 1381US6241961B1Radioimmuno conjugates for use in human therapy and method for their preparationFiled 1999·Granted Jun 5, 2001·52 cites·10 claims
- 1479US7060495B2Fusion proteins for prodrug activationBEHRINGWERKE AG·Filed 1997·Granted Jun 13, 2006·30 cites·23 claims
- 1578US6008023ACytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion proteins in E. coliHOECHST MARION ROUSSEL DE GMBH·Filed 1996·Granted Dec 28, 1999·28 cites·9 claims
- 1675US9072797B2Immunoconjugate for human CD66 for the treatment of multiple myeloma and other haematological malignanciesBENES IVAN·Filed 2006·Granted Jul 7, 2015·2 cites·11 claims
- 1773US7662383B2Chimeric antibody against tumor associated antigens and its use in diagnosing tumorsAVENTIS PHARMA GMBH·Filed 2008·Granted Feb 16, 2010·0 cites·8 claims
- 1873US5877158APro-prodrugs, their production and useBEHRINGWERKE AG·Filed 1994·Granted Mar 2, 1999·45 cites·14 claims
- 1971US6020315APreparation having increased in vivo tolerabilityHOECHST AG·Filed 1998·Granted Feb 1, 2000·35 cites·14 claims
- 2070US5935995AProdrugs for the therapy of tumors and inflammatory disordersHOECHST AG·Filed 1997·Granted Aug 10, 1999·33 cites·16 claims
- 2167US7273727B2Fusion proteins for prodrug activationBEHRINWERKE AG·Filed 2005·Granted Sep 25, 2007·1 cites·14 claims
- 2266US6926896B2Monoclonal antibodies (MAbs) against tumor-associated antigens, the preparation and use thereofAVENTIS PHARMA GMBH·Filed 1994·Granted Aug 9, 2005·17 cites·10 claims
- 2364US7241595B2Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugatesSANOFI AVENTIS PHARMA DEUTSCHL·Filed 2002·Granted Jul 10, 2007·1 cites·20 claims
- 2464US5907034AMonoclonal antibody against complexed and non-complexed complexing agents for removing heavy metals from aqueous solutions and for analysisBEHRING DIAGNOSTICS GMBH·Filed 1995·Granted May 25, 1999·12 cites·17 claims
- 2564US5686583ASpecific antibodies against activated platelets, the preparation thereof and the use thereof in diagnosis and therapyBEHRINGWERKE AG·Filed 1995·Granted Nov 11, 1997·14 cites·16 claims
- 2664US2006159682A1Monoclonal antibodies (MAbs) against tumor-associated antigens, the preparation and use thereofAVENTIS PHARMA GMBH·Filed 2004·Application pending·0 cites
- 2763US7314753B2Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion proteins in E. coliSANOFI AVENTIS DEUTSCHLAND·Filed 2003·Granted Jan 1, 2008·0 cites·7 claims
- 2862US6475486B1Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugatesAVENTIS PHARMA GMBH·Filed 1999·Granted Nov 5, 2002·13 cites·6 claims
- 2961US7605136B2Effector conjugates, methods for their preparation and their pharmaceutical useBAYER SCHERING PHARMA AG·Filed 2003·Granted Oct 20, 2009·0 cites·21 claims
- 3060US2008166362A1New effector conjugates, process for their production and their pharmaceutical useBERGER MARKUS·Filed 2007·Application pending·0 cites
- 3159US2022401594A1Radioimmunoconjugate for use in treating bone marrow associated diseasesTHERAPHARM GMBH·Filed 2022·Application pending·0 cites
- 3256US5643731AUse of pairs of leucine zipper peptides in immunoassay methodsBEHRINGWERKE AG·Filed 1995·Granted Jul 1, 1997·21 cites·14 claims
- 3355US2004091488A1Antigenic constructs of major histocompatibility complex class I antigens with specific carrier molecules, the preparation and use thereofKLAUS BOSSLET DR·Filed 2003·Application pending·0 cites
- 3453US5639621AMonoclonal antibodies against tumor-associated antigensBEHRINGWERKE AG·Filed 1995·Granted Jun 17, 1997·7 cites·8 claims
- 3552US5639622AMonoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereofBEHRINGWERKE AG·Filed 1995·Granted Jun 17, 1997·6 cites·6 claims
- 3649US6610299B1Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugatesAVENTIS PHARMA GMBH·Filed 1994·Granted Aug 26, 2003·14 cites·16 claims
- 3749US5645817AGranulocyte-binding antibody constructs, their preparation and useBEHRINGWERKE AG·Filed 1995·Granted Jul 8, 1997·11 cites·13 claims
- 3848US5837824AEpitope which binds to monoclonal antibodyBEHRING DIAGNOSTICS GMBH·Filed 1995·Granted Nov 17, 1998·3 cites·1 claims
- 3947US8552159B2Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapyBOSSLET KLAUS·Filed 2004·Granted Oct 8, 2013·0 cites·6 claims
- 4045US6294172B1Monoclonal antibodies with specificity for membrane-associated antigensDADE BEHRING MARBURG GMBH·Filed 1995·Granted Sep 25, 2001·14 cites·19 claims
- 4145US2006276413A1New effector conjugates, methods for their preparation and their pharmaceutical useBOSSLET KLAUS·Filed 2006·Application pending·0 cites
- 4245US2008206201A1Recombinant Newcastle Disease VirusBEIER RUDOLF·Filed 2005·Application pending·0 cites
- 4344US5730981AMonoclonal anti-ganglioside antibody and its preparationBEHRINGWERKE AG·Filed 1994·Granted Mar 24, 1998·6 cites·8 claims
- 4443USRE37596EMonoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereofDADE BEHRING MARBURG GMBH·Filed 1999·Granted Mar 19, 2002·4 cites·19 claims
- 4543US5695758AMonoclonal antibodies against tumor-associated antigens, processes for the preparation thereof and the use thereofBEHRINGWERKE AG·Filed 1995·Granted Dec 9, 1997·2 cites·6 claims
- 4643US2009081207A1High affinity human and humanized anti-alpha5beta1 integrin function blocking antibodies with reduced immunogenicityMENRAD ANDREAS·Filed 2007·Application pending·0 cites
- 4740US2005234247A1New effector conjugates, process for their production and their pharmaceutical useKLAR ULRICH·Filed 2005·Application pending·0 cites
- 4839US5674994APolynucleotides encoding the anti-PEM antibody BW835 variable domains and expression vectorsBEHRINGWERKE AG·Filed 1995·Granted Oct 7, 1997·1 cites·8 claims
- 4939US2019388571A1Radioimmunoconjugate for use in treating bone marrow associated diseasesTHERAPHARM GMBH·Filed 2018·Application pending·0 cites
- 5038US2011020282A1Recombinant newcastle disease virusBEIER RUDOLF·Filed 2010·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →